CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 µM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the research of T-cell leukemia and lymphoma[1].
Molecular Weight:
554.68
CAS Number:
[1265822-30-7]
Formula:
C35H34N6O
Target:
Btk
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
